share_log

HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $11

HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $11

HC Wainwright & Co.維持對ProPhase Labs的買入,將目標價下調至11美元
Benzinga ·  2023/11/10 23:27

HC Wainwright & Co. analyst Yi Chen maintains ProPhase Labs (NASDAQ:PRPH) with a Buy and lowers the price target from $14 to $11.

HC Wainwright & Co. 分析師陳毅維持ProPhase Labs(納斯達克股票代碼:PRPH)的買入,並將目標股價從14美元下調至11美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論